blood doping form doping number red blood cells bloodstream boosted order enhance athletic performance blood cells carry oxygen lungs muscles higher concentration blood improve athletes aerobic capacity max blood doping achieved making body produce red blood cells using drugs giving blood transfusions either another person back individual using blood substitutes many methods blood doping illegal particularly professional sports considered give artificial advantage competitor antidoping agencies use tests try identify individuals blood doping using number methods typically analyzing blood samples competitors blood doping defined use illicit products eg erythropoietin epo darbepoetinalfa hypoxiainducible factor hif stabilizers methods eg increase aerobic capacity maximizing uptake order enhance transport body body undergoes aerobic respiration order provide sufficient delivery exercising skeletal muscles main determining factors shown figure rate maximum uptake depends cardiac output extraction hemoglobin mass cardiac output athlete difficult manipulate competitions distribution cardiac output maximum rate ie competitions addition extraction approximately maximal exercise therefore method enhance physical performance left increase content artery enhancing hemoglobin mass words hemoglobin concentration blood volume contribute hemoglobin many forms blood doping stem misuse pharmaceuticals drug treatments created clinical use increase oxygen delivery human body able naturally erythropoietin epo glycoprotein hormone produced interstitial fibroblasts kidney signal erythropoiesis bone marrow increased activity hemocytoblast rbc stem cell allows blood greater carrying capacity oxygen epo first developed counteract effects chemotherapy radiation therapy cancer epo also stimulates increased wound physiological side effects particularly increased hematocrit epo become drug abuse potential professional amateur cyclists hypoxiainducible factor stabilizer hif stabilizer pharmaceutical used treat chronic kidney disease like transcription factors hif transcription factor responsible expression protein hif stabilizer activates activity epo due anemia induced hypoxia metabolic stress creation new blood hif stabilizers used cyclists combination cobalt chloridedesferrioxamine stimulate deregulate natural production erythropoietin physiologically low around mmhg epo released kidneys increase hemoglobin combination drugs consistently releases epo due increased transcription cellular level effect wears hif stabilizers cobalt chloridedesferrioxamine excreted andor decayed body myoinositol trispyrophosphate itpp also known compound number allosteric effector hemoglobin causes rightward shift dissociation curve increasing amount oxygen released red blood cells surrounding tissue passage cardiovascular itpp subject antidoping research blood transfusions traditionally classified autologous blood donor transfusion recipient allogeneichomologous blood transfused someone donor blood transfusion begins withdrawal units blood unit ml blood several weeks competition blood centrifuged plasma components immediately reinfused corpuscular elements principally red blood cells rbcs stored refrigerated frozen blood stored refrigeration displays steady decline number rbcs substantial percentage stored rbcs may freezing process conversely limits aging cells allowing storage blood years loss stored rbcs reinfused usually days highendurance event significant amount iron removed autologous transfusion adequate time recovery less days last donation appropriate iron supplements usually required patients undergoing autologous donations nearly autologous donations used donor discarded current standards allow transfusion units another patient safety reasonscitation needed biochemical biotechnological development allowed novel approaches issue form engineered carriers widely known blood substitutes blood substitutes currently available chiefly polymerized haemoglobin solutions haemoglobinbased oxygen carriers hbocs perfluorocarbons hemoglobinbased oxygen carriers intra intermolecularly engineered human animal hemoglobins optimized oxygen delivery longer intravascular circulation presence within erythrocytes maintains normal affinity hemoglobin oxygen hbocs contain erythrocytes lose interaction thus unmodified human hboc solutions high oxygen affinity compromises function chemical methods developed overcome problem resulted carriers effectively release oxygen physiological peripheral common feature hbocs resistance dissociate dissolved media contrasts hemoglobin natural dissociation nonphysiological conditions hbocs may hypothetically supply greater benefits athletes provided equivalent hemoglobin traditional rbc infusion recent developments shown hbocs simple rbc substitutes highly effective donors terms tissue oxygenation additional effects include increases blood serum iron ferritin increased diffusion oxygen improved exercise increased production lower lactic acid generation anaerobic hbocs shown trials extremely dangerous humans hbocs increase risk death risk myocardial infarction clinical trials ended commercially available us europe approved use pfcs also known fluorocarbons inert waterinsoluble synthetic compounds consisting primarily carbon fluorine atoms bonded together strong bonds pfcs substantially clear colorless liquid emulsions heterogeneous molecular weight surface area electronic charge viscosity high content electrondense fluorine atoms results little intramolecular interaction low surface tension making substances excellent solvents gases especially oxygen carbon molecules dissolve times oxygen plasma pfcs naturally hydrophobic need emulsified injected intravenously since pfcs dissolve rather bind oxygen capacity serve blood substitute determined principally gradients lung target tissue therefore oxygen transport properties differ substantially whole blood especially conventional ambient mmhg oxygen content mll perfluorocarbon less mll whereas optimal oxygen content mll still lower whole blood normal conditions achieved greater mmhg practice conventional alveolar mmhg pfcs able provide sufficient oxygenation peripheral due small size pfcs able permeate circulation erythrocytes may flow tiny capillaries pfcs produce greatest benefit increase local oxygen delivery much efficiently would expected increase oxygen content larger addition gases dissolved state within pfcs promotes efficient oxygen delivery peripheral tissues since improvements oxygen capacity emulsion properties pfcs led development secondgeneration pfcbased oxygen carriers two pfc products currently tested phase iii clinical transition metal complexes widely known play important roles erythropoiesis inorganic supplementation proving emerging technique blood doping particularly note cobalt complex cobalamin vitamin commonly used dietary supplement cobalamin important complex used manufacture red blood cells thus interest potential use blood doping experimental evidence however shown cobalamin effect erythropoiesis absence red blood celloxygen results seem confirm much already known functioning signaling pathway induces erythropoietin secretion subsequently red blood cell manufacture using cobalamin dependent erythropoietin secreted kidneys deficiency rbc manufacture independent amount cobalamin administered deficiency accordingly cobalamin little value blood doping potent use blood doping administered cobaltii chloride cobalt chloride known useful treating anemic recent experimental evidence proved efficacy cobalt chloride blood studies action species shown induces hypoxia like responses relevant response erythropoiesis induces response binding nterminus loop helix loop domain hypoxia inducing transcription factors thus stabilizes protein normal conditions hifs destabilized proline asparagine residues hydroxylated hifÎ± hydroxylases unstable hifs subsequently degraded following ubiquitinproteosome pathway bind activate transcription genes encoding erythropoietin stabilization degradation prevented genes encoding epo activated mechanism n terminus stabilization yet fully understood addition nterminus binding also hypothesized replacement hydroxylase active site could contributing factor stabilizing action understood however binding permits ubiquitin binding prevents proteosomal test detection allogeneichomologous blood transfusion doping implemented flow cytometry method choice examining markers surface blood cells method determine whether blood one person present athletes circulation test utilizes antisera directed blood group antigens obtained donor plasma antigens labeled secondary antibodies conjugated phycoerythrin label igg igmcoated rbcs enhance detection flow cytometry flow cytometry able detect minor variance blood group antigens assessment able distinguish blood subjects earlier received least one unit allogeneic technique able detect small populations cells antigenically distinct individuals autologous blood doping detection done indirectly via co rebreathing technique measure nonphysiologic increases hb mass principle co rebreathing method used currently requires gas mixture inhalation measuring difference carboxyhemoglobin concentration hbco rebreathing volume co binding capacity hb co total hb mass detection method problematic athlete desirable breathe co shortly competition may potentially affect performances detection method hemoglobinbased oxygen carriers ie oxyglobulin done four separate steps step one involves elimination abundance proteins blood samples immunodepletion ie proteo prep plasma immunodepletion process ensures proteins ie albumin immunoglobulin interfere capillary electrophoresis ce separation changing ionization second step ce separation done certain condition case background electrolyte consisting ammonium formate ph order provide sufficient resolution hboc third step uvvis detection performed nm selectively detect hboc hb fourth step timeofflight mass spectrometer allowed increased accuracy selectivity hemoproteins proteins definite determination hboc detection limits ceuvvis nm ceesitofms results plasma cobalt detected laboratory blood analysis intake amount greater Î¼g per day whole blood concentration greater Î¼gl urinary concentration greater Î¼gl least days administration dose increases red blood cell production approximately mg co per day least days oral administration predicted whole blood concentration cobalt exceeds Î¼gl two hours last intake average urine concentrations cobalt exceed Î¼gl within hours intake study carried subjects take Î¼g per day form days model predictions compared study result shows model prediction blood urine median concentration male female groups indicate model predictions sufficiently represent test population early military research scientists studying ways increase fighter pilots tolerance hypoxia high altitude one study red blood cells transfused ten males us naval research facility resulting increased oxygen us special forces commanders fort bragg started experimenting blood doping also known blood loading special forces operators would provide two units whole blood red blood cells would extracted concentrated stored cold temperatures hours mission battle small amount red blood cells would infused back soldier military scientists believe procedure increases soldiers endurance alertness increase bloods capability carry oxygencitation needed australian defence forces approved technique special air service regiment senior nutritionist australian defence science technology organisation chris forbesewan quoted saying unlike sport alls fair love war trying gain advantage potential adversary forbesewan study performanceenhancing drugs techniques rejected six approved caffeine ephedrine energy drinks modafinil creatine blood doping started late outlawed still legal commonly used middle longdistance runners first known case blood doping occurred summer olympics moscow kaarlo maaninka transfused two pints blood winning medals kilometer track races though rules cyclist joop zoetemelk admitted receiving blood transfusions tour de france finished second although claimed intended treat anaemia rather enhance year cyclist francesco moser used blood transfusions prepare successful attempt break hour blood doping banned international olympic committee ioc though test existed cyclist niklas axelsson tested positive epo cyclist tyler hamilton failed fluorescentactivated cell sorting test detecting homologous blood transfusions olympics allowed keep gold medal processing sample precluded conducting second confirmatory test appealed second positive test homologous transfusion vuelta espaÃ±a international court arbitration sport appeal denied hamiltons lawyers proposed hamilton may genetic chimera vanishing twin explain presence red blood cells one person theoretically possible explanations ruled negligible tour de france rider alexander vinokourov astana team tested positive two different blood cell populations thus homologous transfusion according various news reports july vinokourov tested victory stage time trial tour july doping test considered positive second sample tested confirm first vinokourovs b sample tested positive faces possible suspension two years fine equal one years also tested positive stage vinokourovs teammate andrej kashechkin also tested positive homologous blood august days conclusion tour de france race dominated doping scandals team withdrew revelation vinokourov doped according russian investigators new york rangers prospect russian hockey player alexei cherepanov engaged blood doping several months died october collapsing bench game russia also german speed skater fivefold olympic gold medalist claudia pechstein banned two years alleged blood doping based irregular levels reticulocytes blood assumption levels always highest competitions mean reticulocyte count ten years top events like olympic games world championships world cup races mean reticulocyte training phases court arbitration sport confirmed ban november stating possibility blood disease safely september swiss federal supreme court rejected athletes appeal stating pechsteins inherited blood anomaly known die vererbte blutanomalie bekannt gewesen may tyler hamilton turned olympic gold medal us antidoping agency admitting doping minutes interview august lance armstrong stripped seven tour de france titles banned life cyclings governing body following report us antidoping agency accused leading doping program cycling career later admitted using banned substances including blood doping transfusions epo interview oprah winfrey january june ufc fighter chael sonnen tested positive one month later another ufc fighter ali bagautinov also tested positive february bahraini steeplechase steeplechase world record holder ruth jebet tested positive epo march suspended simple act increasing number red blood cells blood may associated hyperviscosity syndrome characterized increased blood viscosity decreased cardiac output blood flow velocity results reduction peripheral oxygen instance overdose epo thicken blood highly viscous arteryclogging sludge increases chances heart attack stroke phlebitis pulmonary embolism seen cases much blood reintroduced blood stream blood doping increases volume red blood cells effectively introduces condition called polycythemia blood disorder known adverse outcomes heart attacks strokes blood contamination preparation storage another issue contamination seen every transfusions red blood cells blood contamination lead sepsis infection affects whole body certain medications used increase red blood cells reduce liver function lead liver failure pituitary problems increases cholesterol httpsenwikipediaorgwikiblooddoping